NEW YORK (GenomeWeb) – New England Peptide and SISCAPA Assay Technologies are collaborating to manufacture and sell stable isotope standard peptides for use in SISCAPA's protein quantification assays.
Under the terms of the deal announced today, NEP will manufacture peptide standards that can be used on the assays. The peptides will be used with SISCAPA's validated monoclonal anti-peptide antibodies so that licensees of SISCAPA's will have standardized, high-sensitivity measurements of proteins by mass spectrometry, the partners said.
They added that SISCAPA assays mitigate the limited specificity and protein interferences that may occur with ligand binding assays and anti-protein immunocapture mass spectrometry.
"As our menu of validated SISCAPA tests continues to expand, mass spectrometry customers, who are accustomed to very high precision, need the highest quality peptide internal standards," SISCAPA's VP of Marketing and Sales Selena Larkin said in a statement. "We feel that NEP brings that to our growing customer base."
Financial and other terms of the deal were not disclosed.